The decision depends on weight loss progress, side effects, health markers, maintenance planning and provider guidance
doi: Smits, M
In the event of a nationwide shortage, in which Ozempic is commercially unavailable according to the FDA, your physician may recommend compounded semaglutide (the active ingredient in Ozempic ) as an alternative.* *Due to the Ozempic shortage, specific dose strengths, particularly starter doses, may be unavailable
Semaglutide, marketed as Wegovy, addresses the significant market for chronic weight management
Best For Recommendations# Proven Efficacy and Safety# Recommendation : Semaglutide Reason : FDA-approved since 2017 with over 25,000 clinical trial participants, proven cardiovascular benefit (SELECT trial), and 7+ years of post-marketing surveillance